# OnCo record paper-annala-ctdna-resistance-abiraterone-enzalutamide-cancer-discov-2018 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-annala-ctdna-resistance-abiraterone-enzalutamide-cancer-discov-2018/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-annala-ctdna-resistance-abiraterone-enzalutamide-cancer-discov-2018" ;
  schema:name "Circulating tumour DNA genomics correlate with resistance to abiraterone and enzalutamide in prostate cancer"@en ;
  schema:description "A blood test taken before the first tablet identified the men whose disease would resist both standard hormone drugs, which the clinical variables could not do."@en ;
  schema:url <https://onco.cc/key-papers/paper-annala-ctdna-resistance-abiraterone-enzalutamide-cancer-discov-2018/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://doi.org/10.1158/2159-8290.CD-17-0937>, <https://pubmed.ncbi.nlm.nih.gov/29367197/> ;
  schema:sameAs <https://doi.org/10.1158/2159-8290.CD-17-0937> ;
  schema:datePublished "2018"^^xsd:gYear ;
  schema:author "Annala M, Vandekerkhove G, Khalaf D, et al." ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-mcrpc/> ;
  onco:technologies <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/wes-wgs/> ;
  onco:targets <https://onco.cc/targets/brca/>, <https://onco.cc/targets/atm/>, <https://onco.cc/targets/tp53/>, <https://onco.cc/targets/androgen-receptor/> ;
  onco:drugs <https://onco.cc/drugs/abiraterone/>, <https://onco.cc/drugs/enzalutamide/> ;
  onco:pathways <https://onco.cc/pathways/ar-signaling/>, <https://onco.cc/pathways/homologous-recombination-repair/>, <https://onco.cc/pathways/p53-cell-cycle/>, <https://onco.cc/pathways/resistance-routes-map/> ;
  onco:terms <https://onco.cc/terms/ctdna/>, <https://onco.cc/terms/cfdna/>, <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/terms/resistance/>, <https://onco.cc/terms/castration-resistance/> ;
  onco:journals <https://onco.cc/journals/cancer-discovery/> .